Suzhou Zelgen Biopharmaceuticals Co.,ltd
Clinical trials sponsored by Suzhou Zelgen Biopharmaceuticals Co.,ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for tough cancers: experimental drug ZG006 enters human trials Results expected Sep 2026 (estimated)
- New hope for advanced cancer? experimental drug ZGGS18 enters human trials Results expected Nov 2026 (estimated)
- Healthy volunteers test two versions of experimental drug Results expected Feb 2027 (estimated)
- New drug duo targets tough lymphoma Results expected Apr 2027 (estimated)
- New combo aims to tackle lung cancer after immunotherapy fails Results expected Apr 2027 (estimated)